Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)
Fluticasone Propionate Aerosol, Metered
Product Images NDC 66993-079
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 66993-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)
Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)
This appears to be a chart or graph related to a study on the effects of Fluticasone Propionate inhalers at different dosages on FEV (forced expiratory volume) in comparison to a placebo. The x-axis represents the weeks of the study, while the y-axis measures the percentage change in FEV from the baseline. Unfortunately, the chart is not readable due to the presence of special characters and typos obtained by the .*
Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)
The text seems to be showing data related to the percentage of subjects with an increase in dose and a reduction in dose for Fluticasone Propionate HFA medication. The percentage of subjects with a reduction in dose is not specified but there are percentages given for different dose levels. The term "Il Piacebo" is not clear in this context and could be a typo.*
Figure A (Fluticasonepropionatehfa Spl Graphic 05)
This is a description of a metal canister that comes with a dark orange plastic actuator and mouthpiece. The canister is closed off by a peach-colored cap.*
Figure B (Fluticasonepropionatehfa Spl Graphic 06)
Figure C (Fluticasonepropionatehfa Spl Graphic 07)
Figure D (Fluticasonepropionatehfa Spl Graphic 08)
Figure E (Fluticasonepropionatehfa Spl Graphic 09)
The text appears to be describing the position of a mouthpiece that is down, with a color appearing to be dark orange. It is not clear what item this mouthpiece belongs to, but it could potentially be a musical instrument or a breathing device.*
Figure F (Fluticasonepropionatehfa Spl Graphic 10)
This text seems to be a simple instruction to breathe out as much air as one can.*
Figure G (Fluticasonepropionatehfa Spl Graphic 11)
Figure H (Fluticasonepropionatehfa Spl Graphic 12)
Figure I (Fluticasonepropionatehfa Spl Graphic 13)
Figure J (Fluticasonepropionatehfa Spl Graphic 14)
Fluticasone Propionate Hfa 44 Mcg 120 Dose Carton (Fluticasonepropionatehfa Spl Graphic 15)
This is a description of a medication called Fluticasone Propionate HFA Inhalation Aerosol, manufactured by Prasco, with NDC code 66993-076-96. It is an inhaler that contains a suspension of micronized fluticasone propionate in a propellant called HFA-134a. Each actuation of the inhaler delivers 50 mcg of fluticasone propionate from the valve and 44 mcg from the actuator. The net weight is 10.6g, and it offers 120 metered actuations. It is important to note that the inhaler should only be used with the Fluticasone Propionate HFA actuator.*
Fluticasone Propionate 110 Mcg 120 Dose Carton (Fluticasonepropionatehfa Spl Graphic 16)
This is a medication with the National Drug Code (NDC) of 66993-079-96 manufactured by PRASCO. The medication is an inhalation aerosol of Fluticasone Propionate HFA which is only intended for oral inhalation with a Fluticasone Propionate HFA actuator. The canister contains a microcrystalline suspension of fluticasone propionate in propellant HFA-134a. Each actuation of the inhaler delivers 125 mcg of fluticasone propionate from the valve and 110 mcg from the actuator. The medication has a net weight of 12g and can deliver 120 metered actuations.*
Fluticasone Propionate Hfa 220 Mcg Dose Carton (Fluticasonepropionatehfa Spl Graphic 17)
This is a description of a medication called Fluticasone Propionate HIFA, which is an inhalation aerosol used for oral inhalation with a specific Fluticasone Propionate HFA actuator. It contains a microcrystalline suspension of micronized fluticasone propionate in propellant HFA-134a, and each actuation delivers 250 mcg of fluticasone propionate from the valve and 220 mcg from the actuator. The medication is available in a canister with a net weight of 12 g and 120 metered actuations.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
